TITLE:
      Quality of Life Among Survivors of Hodgkin Lymphoma
SUMMARY:
      The purpose of this study is to collect information on the long-term side effects of
      treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin
      Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma
      survivors' health and quality of life.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment
             of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).

          -  English speaking

        Exclusion Criteria:
